Form
SCHEDULE 13D
Active or control-oriented beneficial ownership filing.
EW HEALTHCARE PARTNERS FUND 2, L.P. - 09 Jun 2026 SCHEDULE 13D Report for TELA Bio, Inc. Common Stock, par value $0.001 per share (TELA)
- Filing manager
- EW HEALTHCARE PARTNERS FUND 2, L.P.
- Reporting owner
- EW Healthcare Partners Fund 2-GP, L.P.
- Beneficially owned shares
- 7,714,709 shares
- Large-stake signal
-
Ownership
17%Beneficial ownership of this reported class.
Shares
7,714,709 sharesShares beneficially owned as disclosed.
Event date
09 Jun 2026Date tied to the ownership event or amendment.
Accepted by SEC
09 Jun 2026EDGAR acceptance date.
How to read this large-stake filing
- Schedule 13D/G filings focus on beneficial ownership stakes, not a full portfolio.
- Compare this filing with the holder history and issuer page before treating the percentage as a current position.
- Use amendments to understand whether the disclosed stake increased, decreased, or changed reporting status.
- Class ownership
- 17%
- Symbol
- TELA
- Shares outstanding
- 44,774,864 shares
- SEC form
- SCHEDULE 13D
- Accepted by SEC
- 09 Jun 2026, 18:29:21 UTC
- Event date
- 09 Jun 2026
- Prior SEC filing
- 17 Nov 2025
- Source filing
- View source filing
Ownership signal
CIK-linked ownership evidence from parsed SEC filings.
2 signals
Subject security
Names, identifiers, and filing context for this profile.
2 source fields
Source evidence
Original filing metadata and source links for verification.
5 source fields
Key filing fact
EW HEALTHCARE PARTNERS FUND 2, L.P. disclosed 17% ownership in TELA Bio, Inc. Common Stock, par value $0.001 per share (TELA) on 09 Jun 2026.
Key facts
- EW HEALTHCARE PARTNERS FUND 2, L.P. filed SCHEDULE 13D for TELA Bio, Inc. Common Stock, par value $0.001 per share (TELA).
- Disclosed ownership: 17%.
- Date of event: 09 Jun 2026.
Change
- Previous schedule filing date: 17 Nov 2025.
- Current filing was accepted on 09 Jun 2026, 18:29.
Research use
- This page turns one Schedule 13D/G filing into a quick large-stake read before the raw reporting-person rows.
- Use the linked SEC filing as the source of truth for ownership percentages, shares, and reporting-party details.
Evidence
Backed by Schedule 13D/13G
View source filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting persons
Disclosed reporting parties (4)
Names, ownership percentages, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.
| Name | Ownership | Shares owned | Sole voting power | Shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| EW HEALTHCARE PARTNERS FUND 2, L.P. | 6.8% | 3,031,617 | 3,031,617 | 0 | /s/ R. Scott Barry | EW Healthcare Partners Fund 2-GP, L.P., its General Partner, EW Healthcare Partners Fund 2-UGP, LLC, its General Partner, R. Scott Barry, Manager | 0001746777 |
| EW HEALTHCARE PARTNERS FUND 2-A, L.P. | 10% | 4,683,092 | 4,683,092 | 0 | /s/ R. Scott Barry | EW Healthcare Partners Fund 2-GP, L.P., its General Partner, EW Healthcare Partners Fund 2-UGP, LLC, its General Partner, R. Scott Barry, Manager | 0001746779 |
| EW Healthcare Partners Fund 2-GP, L.P. | 17% | 7,714,709 | 7,714,709 | 0 | /s/ R. Scott Barry | EW Healthcare Partners Fund 2-UGP, LLC, its General Partner, R. Scott Barry, Manager | 0001793943 |
| EW Healthcare Partners Fund 2-UGP, LLC | 17% | 7,714,709 | 7,714,709 | 0 | /s/ R. Scott Barry | R. Scott Barry, Manager | 0001793948 |
CIK / CUSIP context first